Wednesday’s (19th July) announcement from the Joint Committee on Vaccination and Immunisation (JCVI) was disappointing. We heard that not only has a final decision on extending the HPV vaccination to boys not been made, but that the committee is unable to recommend an extension based on cost-effectiveness.
Categories: HPV Chief Executive blog Policy Vaccination